Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022

[Image: see text] The accelerated appearance of drug-resistant bacteria poses an ever-growing threat to modern medicine’s capacity to fight infectious diseases. Gram-positive species such as methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae continue to contribute signif...

Descripción completa

Detalles Bibliográficos
Autores principales: van Groesen, Emma, Innocenti, Paolo, Martin, Nathaniel I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379927/
https://www.ncbi.nlm.nih.gov/pubmed/35895325
http://dx.doi.org/10.1021/acsinfecdis.2c00253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379927/
https://www.ncbi.nlm.nih.gov/pubmed/35895325
http://dx.doi.org/10.1021/acsinfecdis.2c00253

Ejemplares similares